| Detected | Trial | Change |
|---|---|---|
| 2026-07-17 | NCT07438496 A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus |
Trial sites expanded: 169 -> 222 locations |
| 2026-07-17 | NCT07258511 A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3… |
Primary endpoint(s) modified |
| 2026-07-17 | NCT07258511 A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3… |
Trial sites expanded: 103 -> 109 locations |
| 2026-07-11 | NCT07308132 A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies |
Trial sites expanded: 9 -> 19 locations |
| 2026-07-08 | NCT01804686 A Long-term Extension Study of PCI-32765 (Ibrutinib) |
date change Completion pushed: 2029-12-31 -> 2030-12-31 |
| 2026-07-07 | NCT07582783 A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe… |
Trial sites expanded: 6 -> 19 locations |
| 2026-07-07 | NCT05327114 Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory… |
Trial sites expanded: 115 -> 118 locations |
| 2026-07-07 | NCT07228312 A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial… |
Trial sites expanded: 3 -> 8 locations |
| 2026-07-07 | NCT07589634 A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release… |
Recruitment opened |
| 2026-07-07 | NCT06150157 A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated… |
Trial sites expanded: 33 -> 36 locations |
| 2026-07-07 | NCT06150157 A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated… |
date change Completion pushed: 2028-05-12 -> 2028-06-14 |
| 2026-07-07 | NCT06852222 A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… |
Trial sites expanded: 250 -> 253 locations |
| 2026-07-07 | NCT06385080 A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants… |
date change Primary completion pushed: 2027-12-27 -> 2032-12-27 |
| 2026-07-07 | NCT06807424 A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in… |
Trial sites expanded: 216 -> 224 locations |
| 2026-07-07 | NCT02494986 A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1)… |
date change Completion moved earlier: 2027-06-30 -> 2026-08-18 |
| 2026-07-07 | NCT07669077 A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women |
Recruitment opened |
| 2026-07-07 | NCT06120140 Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor… |
date change Completion moved earlier: 2032-01-31 -> 2030-06-30 |
| 2026-07-07 | NCT07586202 A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… |
Recruitment opened |
| 2026-07-07 | NCT07266441 A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma |
Trial sites expanded: 51 -> 69 locations |
| 2026-07-07 | NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… |
Trial sites expanded: 6 -> 26 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-25 | NCT07669077 A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women | Phase 1 | Recruiting |
| 2026-06-24 | NCT07665450 A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07053345 | A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant… | Depressive Disorder, Treatment-Resistant | Recruiting |
| NCT05201781 | A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel | Multiple Myeloma | Recruiting |
| NCT07030517 | A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and… | Multiple Myeloma | Recruiting |
| NCT07141004 | A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants… | Arthritis, Psoriatic | Recruiting |
| NCT07310095 | A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's… | Crohn Disease | Recruiting |
| NCT04108208 | A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT04929210 | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active… | Arthritis, Psoriatic | Active, Not Recruiting |
| NCT07654751 | A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are… | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Myasthenia Gravis | Recruiting |
| NCT05438043 | A Study of Daratumumab | Multiple Myeloma | Recruiting |
| NCT06208150 | A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and… | Multiple Myeloma | Recruiting |
| NCT07225946 | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic… | Prostatic Neoplasms, Castration-Resistant | Recruiting |
| NCT04892173 | JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | Carcinoma, Squamous Cell | Recruiting |
| NCT05552222 | A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and… | Multiple Myeloma | Recruiting |
| NCT05912517 | A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus… | Hemolytic Disease of the Fetus and Newborn | Recruiting |
| NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… | Crohn's Disease | Recruiting |
| NCT06319820 | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT06449651 | A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune… | Thrombocytopenia, Neonatal Alloimmune | Recruiting |
| NCT06533098 | A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of… | Thrombocytopenia, Neonatal Alloimmune | Recruiting |
| NCT06559306 | Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants… | Depressive Disorder, Major | Recruiting |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… | Colorectal Neoplasms | Recruiting |
| NCT06663332 | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants | Crohns Disease | Recruiting |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… | Colorectal Neoplasms | Recruiting |
| NCT06807424 | A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in… | Arthritis, Psoriatic | Recruiting |
| NCT06852222 | A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… | Leukemia, Myeloid, Acute | Recruiting |